List of designer drugs

Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal. Some designer drugs (research chemicals) are structural analogues of psychoactive tryptamines or phenethylamines but there are many other chemically unrelated psychoactive substances that can be considered part of the designer drug group.[1][2][3][4] Designer drugs also include analogues of controlled anabolic steroids. The pharmaceutical activities of these compounds might not be predictable based strictly upon structural examination. Many of the substances have common effects while structurally different or different effects while structurally similar due to SAR paradox. As a result of no real official naming for some of these compounds, as well as regional naming, this can all lead to potentially hazardous mix ups for users.[5] The following list is not exhaustive.


A psychedelic substance is a psychoactive drug whose primary action is to alter cognition and perception. Psychedelics tend to affect and explore the mind in ways that result in the experience being qualitatively different from those of ordinary consciousness. The psychedelic experience is often compared to non-ordinary forms of consciousness such as trance, meditation, yoga, religious ecstasy, dreaming and even near-death experiences.


Lysergamides are amide derivatives of the alkaloid lysergic acid.

  • 1P-ETH-LAD, 1-Propionyl-ETH-LAD
  • 1P-LSD, 1-Propionyl-LSD
  • ALD-52, 1-Acetyl-LSD
  • AL-LAD, 6-Allyl-6-Nor-LSD
  • ETH-LAD, 6-Ethyl-6-Nor-LSD
  • LSM-775, N-Morpholinyllysergamide
  • LSZ, LA-SS-Az


Drugs containing the tryptamine moiety are typically substrates for the serotonin receptors, in keeping with their close structural resemblance to serotonin, a neurotransmitter.



Drugs containing the phenethylamine moiety bear close structural resemblance to dopamine but substitution on the benzene ring gives rise to drugs with a much higher affinity for serotonin receptors.


2C-x class of psychedelics are 2,5-dimethoxy-phenethylamine derivatives.



The DOx family of psychedelics are also known as "substituted amphetamines" as they contain the amphetamine backbone but are substituted on the benzene ring. This gives rise to serotonin agonists similar to the 2C-X class but more resistant to elimination in the body.


Dissociatives are a class of hallucinogens which distort perceptions of sight and sound and produce feelings of detachment - dissociation - from the environment and self. This is done through reducing or blocking signals to the conscious mind from other parts of the brain. Although many kinds of drugs are capable of such action, dissociatives are unique in that they do so in such a way that they produce hallucinogenic effects, which may include sensory deprivation, dissociation, hallucinations, and dream-like states or trances. Some, which are nonselective in action and affect the dopamine and/or opioid systems, may be capable of inducing euphoria. Many dissociatives have general depressant effects and can produce sedation, respiratory depression, analgesia, anesthesia, and ataxia, as well as cognitive and memory impairment and amnesia.


Arylcyclohexylamines are the oldest and most widely used dissociatives. The class includes the well known anaesthetic, ketamine.


Diarylethylamines began to appear on grey markets only as recently as 2013.



Piperazine containing designer drugs have effects similar to MDMA (ecstasy). This class of drugs are mimics of serotonin that activate 5-HT receptor subtypes that release norepinephrine and dopamine.


Empathogens are a class of psychoactive drugs that produce distinctive emotional and social effects similar to those of MDMA . Users of empathogens say the drugs often produce feelings of empathy, love, and emotional closeness to others.


Substituted methylenedioxyphenethylamines (MDxx) are a large chemical class of derivatives of the phenethylamines, which includes many psychoactive drugs that act as entactogens, psychedelics, and/or stimulants, as well as entheogens.


Benzofurans are similar in structure to MD(M)A but differ in that the methylenedioxy groups have been modified, removing one of the two oxygens in the methylenedioxy ring to render a benzofuran ring.

Miscellaneous polycyclic phenethylamines

Indane and tetralin-type phenethylamines are vaguely related to their amphetamine analogues.

Only one non-tryptamine indole has been sold, 5-IT. It shows strong MAOI activity.


Drugs containing the tryptamine moiety are typically substrates for the serotonin receptors, in keeping with their close structural resemblance to serotonin, a neurotransmitter.

  • αET, α-Ethyltryptamine, "Monase"
  • 5-MeO-αET, α,O-Diethylserotonin
  • αMT, α-Methyltryptamine, "Indopan"
  • 5-MeO-αMT, α,O-Dimethylserotonin


Substituted amphetamines are a chemical class of stimulants, entactogens, hallucinogens, and other drugs. They feature a phenethylamine core with a methyl group attached to the alpha carbon resulting in amphetamine, along with additional substitutions.

  • 4-BA, 4-Bromoamphetamine, PBA
  • 4-CA, 4-Chloroamphetamine, PCA
  • 4-CMA, 4-Chloromethamphetamine, PCMA
  • 4-FA, 4-Fluoroamphetamine, PFA
  • 4-FMA, 4-Fluoromethamphetamine, PFMA
  • 4-MA, 4-Methylamphetamine, PAL-313
  • 4-MeOA, 4-Methoxyamphetamine, PMA, 4-MeO-A, "Death"
  • 4-MeOMA, 4-Methoxymethamphetamine, PMMA, 4-MeO-MA
  • 4-MTA, 4-Methylthioamphetamine
  • Methamnetamine, N-Methyl-PAL-287, Methylnaphetamine, MNT, MNA
  • MMA, 3-Methoxy-4-Methylamphetamine


Stimulants produce a variety of different kinds of effects by enhancing the activity of the central and peripheral nervous systems. Common effects, which vary depending on the substance and dosage in question, may include enhanced alertness, awareness, wakefulness, endurance, productivity, and motivation, increased arousal, locomotion, heart rate, and blood pressure, and the perception of a diminished requirement for food and sleep.


Amphetamines are a chemical class of stimulants, entactogens, hallucinogens, and other drugs. They feature a phenethylamine core with a methyl group attached to the alpha carbon resulting in amphetamine, along with additional substitutions.


Cathinones include some stimulants and entactogens, which are derivatives of cathinone. They feature a phenethylamine core with an alkyl group attached to the alpha carbon, and a ketone group attached to the beta carbon, along with additional substitutions.

Pyrrolidines and Pyrrolidinophenones

Pyrrolidines are amphetamines with a pyrrolidine group. Pyrrolidinophenones (also called Pyrovalerones) are cathinones (βk-amphetamines) with a pyrrolidine group.


Thiophenes are stimulant drugs which are analogues of amphetamine or cathinone where the phenyl ring has been replaced by thiophene.

Tropanes and Piperidines

Tropane alkaloids occur in plants of the families erythroxylaceae (including coca). Piperidine and its derivatives are ubiquitous building blocks in the synthesis of many pharmaceuticals and fine chemicals.


Oxazolidines are a five-membered ring compounds consisting of three carbons, a nitrogen, and an oxygen. The oxygen and NH are the 1 and 3 positions, respectively. In oxazolidine derivatives, there is always a carbon between the oxygen and the nitrogen.


Phenylmorpholines are a class of stimulants containing a phenethylamine skeleton in which the terminal amine is incorporated into a morpholine ring.

  • Isophenmetrazine, PAL-730[56]
  • 2-Hydroxy-4'-Ethylphenmetrazine, 2-HO-4'-EPM, 2-Hydroxyphenmetetrazine, N-Ethylphenmetrazol
  • 3,4-Methylenedioxyphendimetrazine, MDMPM
  • 3-Fluorophenetrazine, 3-FPE[57]
  • 3-Fluorophenmetrazine, 3-FPM, PAL-593
  • 3-Methylphenmetrazine, 3-MPM, PAL-773
  • N-Ethylphenmetrazine, Phenmetetrazine[58]
  • 4-Methylphenmetrazine, 4-MPM
  • 6-Methylphenmetrazine, 6-MPM
  • G-130
  • Methylmorphenate
  • PDM-35, 5-Methylphenmetrazine, 5-MPM
  • Phenetrazine, PE[59]
  • Viloxazine



Sedatives are substances that induces sedation by reducing irritability or excitement. At higher doses they may result in slurred speech, staggering gait, poor judgment, and slow, uncertain reflexes. Doses of sedatives such as benzodiazepines, when used as a hypnotic to induce sleep, tend to be higher than amounts used to relieve anxiety, whereas only low doses are needed to provide a peaceful effect. Sedatives can be misused to produce an overly-calming effect. In the event of an overdose or if combined with another sedative, many of these drugs can cause unconsciousness and even death.


See also: List of opioids

Opioids have pharmacologic actions resembling morphine and other components of opium.



GHB analogues

Methaqualone analogues


Synthetic cannabinoid

Main article: Synthetic cannabinoid

Agonists of the central cannabinoid receptor type 1 mimic the behavioral effects of cannabis.

Classical cannabinoids

Miscellaneous cannabinoids

Indazole based

Indazole containing cannabinoid receptor agonists include:

Indole based

Indole containing cannabinoid receptor agonists include:







Androgenic anabolic steroids have approved medical uses as well as used illicitly as performance-enhancing drugs to build muscle mass and strength. Anabolic steroids that have been designed to evade detection in sport doping tests are known as "designer steroids".[84][85]

Testosterone based

DHT based



Selective androgen receptor modulators (SARMs) are a novel class of androgen receptor ligands. They are intended to maintain the desirable muscle building effects of anabolic steroids while reducing undesirable androgenic actions (e.g., increased risk of prostate cancer). SARMs that are more selective in their action potentially could be used for a wider range clinical indications than the relatively limited legitimate uses that anabolic steroids are currently approved for.[86]



GHRH analogues

GHRH analogues stimulate the release of growth hormone.

Growth hormone secretagogue receptor agonists

Agonists of the growth hormone secretagogue receptor regulate energy homeostasis and body weight.


PDE5 inhibitors

PDE5 inhibitors are typically used to treat erectile dysfunction and improve sexual stamina.


Nootropics are drugs that improve one or more aspects of mental function, such as working memory, motivation, and attention.


Racetams are a class of drugs that share a pyrrolidone nucleus. Many, such as piracetam, but not all, are considered nootropics.

See also


  1. "EMCDDA–Europol 2013 Annual Report on the information exchange, risk assessment and control of new psychoactive substances (implementation of Council Decision 2005/387/JHA)". EMCDDA. July 2014. Retrieved 8 August 2014.
  2. "EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)". EMCDDA. May 2013. Retrieved 8 August 2014.
  3. "EMCDDA–Europol 2011 Annual Report on the (information exchange, risk assessment and control of new psychoactive substances) implementation of Council Decision 2005/387/JHA". EMCDDA. April 2012. Retrieved 8 August 2014.
  4. "EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA". EMCDDA. May 2011. Retrieved 8 August 2014.
  5. Shimizu E, Watanabe H, Kojima T, Hagiwara H, Fujisaki M, Miyatake R, Hashimoto K, Iyo M (Jan 2007). "Combined intoxication with methylone and 5-MeO-MIPT". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31 (1): 288–91. doi:10.1016/j.pnpbp.2006.06.012. PMID 16876302.
  6. "4-AcO-DPT". PubChem.
  7. "4-HO-DALT". Isomerdesign.
  8. Uchiyama N, Miyazawa N, Kawamura M, Kikura-Hanajiri R, Goda Y (2010). "[Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008]". Yakugaku Zasshi (in Japanese). 130 (2): 263–70. doi:10.1248/yakushi.130.263. PMID 20118651.
  9. "5-MeO-MET". Isomerdesign.
  10. "5-MeO-NiPT". Isomerdesign.
  11. "McPT". New Synthetic Drugs Database.
  12. Daniel Trachsel; David Lehmann; Christoph Enzensperger (2013). Phenethylamine Von der Struktur zur Funktion. Nachtschatten Verlag AG. ISBN 978-3-03788-700-4.
  13. "25B-NBF". Cayman Chemical. Retrieved 27 December 2014.
  14. "25C-NBF". Cayman Chemical. Retrieved 27 December 2014.
  15. "25iP-NBOMe". New Synthetic Drugs Database.
  16. 1 2 3 4 5 6 7 Kaizaki-Mitsumoto, Asuka; Noguchi, Naoki; Yamaguchi, Saki; Odanaka, Yuki; Matsubayashi, Satoko; Kumamoto, Hiroki; Fukuhara, Kiyoshi; Funada, Masahiko; Wada, Kiyoshi; Numazawa, Satoshi (January 2016). "Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market". Forensic Toxicology. 34 (1): 108–114. doi:10.1007/s11419-015-0293-6. ISSN 1860-8965.
  17. "C30-NBOMe". Forendex. Southern Association of Forensic Scientists. Retrieved 13 August 2014.
  18. "Mescaline-NBOMe". Cayman Chemical. Retrieved 29 September 2015.
  19. "deschloro-N-ethyl-Ketamine". Cayman Chemical.
  20. Morris H, Wallach J (2014). "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs". Drug Test Anal. 6 (7-8): 614–32. doi:10.1002/dta.1620. PMID 24678061.
  21. "DB-MDBP". New Synthetic Drugs Database.
  22. "Dimethylone". Forendex. Southern Association of Forensic Scientists. Retrieved 13 August 2014.
  23. "N,N-Dimethylpentylone". Cayman Chemical. Retrieved 29 September 2015.
  24. "EFLEA". New Synthetic Drugs Database.
  25. 1 2 Uchiyama, Nahoko; Shimokawa, Yoshihiko; Kikura-Hanajiri, Ruri; Demizu, Yosuke; Goda, Yukihiro; Hakamatsuka, Takashi (1 July 2015). "A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology. 33 (2): 244–259. doi:10.1007/s11419-015-0268-7. ISSN 1860-8965. PMC 4525202Freely accessible. PMID 26257833.
  26. "5-MBPB". New Synthetic Drugs Database.
  27. "2-FMC" (PDF). SWGDRUG. 2013. Retrieved 19 August 2014.
  28. "2-Methylethcathinone". Cayman Chemical. Retrieved 6 September 2015.
  29. "2-MMC" (PDF). SWGDRUG. 2013. Retrieved 19 August 2014.
  30. "2,4-DMEC". New Synthetic Drugs Database.
  31. "2,4-DMMC". New Synthetic Drugs Database.
  32. "3-Chloromethcathinone". Cayman Chemical. Retrieved 29 September 2015.
  33. "3-Ethylethcathinone". Cayman Chemical. Retrieved 29 September 2015.
  34. "3-MeOMC". Cayman Chemical. Retrieved 27 December 2014.
  35. "3-MEC" (PDF). SWGDRUG. 2013. Retrieved 19 August 2014.
  36. "4-BEC". New Synthetic Drugs Database.
  37. Siemer Harm (11 April 1967). "US Patent 3313687 - Appetite-suppressing and weight reducing composition".
  38. "4-CMC". Cayman Chemical. Retrieved 27 December 2014.
  39. "4F-IVP". Cayman Chemical. Retrieved 29 September 2015.
  40. "4-FPD". Cayman Chemical. Retrieved 7 April 2015.
  41. 1 2 3 4 5 Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y (2014). "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products". Forensic Sci. Int. 243: 1–13. doi:10.1016/j.forsciint.2014.03.013. PMID 24769262.
  42. "4-methyl-N,N-DMC". Cayman Chemical. Retrieved 7 April 2015.
  43. Weiß JA, Taschwer M, Kunert O, Schmid MG (2014). "Analysis of a new drug of abuse: Cathinone derivative 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one (DL-4662)". J Sep Sci. 38: 825–8. doi:10.1002/jssc.201401052. PMID 25545103.
  44. "NiPP". New Synthetic Drugs Database.
  45. "βk-IVP". New Synthetic Drugs Database.
  46. Gaspar H, Bronze S, Ciríaco S, Queirós CR, Matias A, Rodrigues J, Oliveira C, Cordeiro C, Santos S (May 2015). "4F-PBP (4'-fluoro-α-pyrrolidinobutyrophenone), a new substance of abuse: Structural characterization and purity NMR profiling". Forensic Science International. 252: 168–176. doi:10.1016/j.forsciint.2015.05.003. PMID 26005857.
  47. Kaori Shintani-Ishida; Mami Nakamura; Misa Tojo; Nozomi Idota; Hiroshi Ikegaya (May 2015). "Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC–TOF-MS in an autopsy case". Forensic Toxicology. 33: 348–354. doi:10.1007/s11419-015-0281-x.
  48. "5-PPDI". New Synthetic Drugs Database.
  49. "α-PBT". Cayman Chemical. Retrieved 27 December 2014.
  50. "TH-PVP". New Synthetic Drugs Database.
  51. "5-BPDI". New Synthetic Drugs Database.
  52. "3,4-MDPHP". Cayman Chemical. Retrieved 7 April 2015.
  53. "PV-8". Forendex. Southern Association of Forensic Scientists. Retrieved 13 August 2014.
  54. "4-MeO-PV-9". Cayman Chemical. Retrieved 27 December 2014.
  55. "PV-10". Cayman Chemical. Retrieved 7 April 2015.
  56. "Isophenmetrazine". New Synthetic Drugs Database.
  57. "3-FPE". New Synthetic Drugs Database.
  58. "Phenmetetrazine". New Synthetic Drugs Database.
  59. "Phenetrazine". New Synthetic Drugs Database.
  60. Power JD, Scott KR, Gardner EA, Curran McAteer BM, O'Brien JE, Brehon M, Talbot B, Kavanagh PV (January 2014). "The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine". Drug Testing and Analysis. 6 (7-8): 668–75. doi:10.1002/dta.1616. PMID 24574100.
  61. "Modafiendz". New Synthetic Drugs Database.
  62. "2-(3,4-Dichlorophenyl)-N-[(1S,2S)-2-(dimethylamino)cyclohexyl]-N-methylacetamide". ChemSpider.
  63. "Cloniprazepam". New Synthetic Drugs Database.
  64. Laura M. Huppertz; Philippe Bisel; Folker Westphal; Florian Franz; Volker Auwärter; Bjoern Moosmann (April 2015). "Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites". Forensic Toxicology. 33: 388–395. doi:10.1007/s11419-015-0277-6.
  65. "EG-018". Cayman Chemical. Retrieved 9 August 2014.
  66. "EG-2201". Cayman Chemical. Retrieved 27 October 2015.
  67. "MDMB-CHMCZCA". New Synthetic Drugs Database.
  68. 1 2 3 Zhenhua Qian; Wei Jia; Tao Li; Zhendong Hua; Cuimei Liu (2016). "Identification and analytical characterization of four synthetic cannabinoids ADB-BICA, NNL-1, NNL-2, and PPA(N)-2201". Drug Testing and Analysis. doi:10.1002/dta.1990.
  69. "5C-APINACA". New Synthetic Drugs Database.
  70. "5F-MN-18". Forendex. Southern Association of Forensic Scientists. Retrieved 12 August 2014.
  71. "5F-NPB-22". Cayman Chemical. Retrieved 9 May 2015.
  72. "5F-SDB-005". Forendex. Southern Association of Forensic Scientists. Retrieved 13 August 2014.
  73. 1 2 Qian, Zhenhua; Hua, Zhendong; Liu, Cuimei; Jia, Wei (January 2016). "Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances". Forensic Toxicology. 34 (1): 133–143. doi:10.1007/s11419-015-0297-2. ISSN 1860-8965. PMC 4705129Freely accessible. PMID 26793280.
  74. "AMB". Forendex. Southern Association of Forensic Scientists. Retrieved 13 August 2014.
  75. Jun’ichi Nakajima, Misako Takahashi, Nozomi Uemura, Takako Seto, Haruhiko Fukaya, Jin Suzuki, Masao Yoshida, Maiko Kusano, Hiroshi Nakayama, Kei Zaitsu, Akira Ishii, Takako Moriyasu, Dai Nakae (November 2014). "Identification of N,N-bis(1-pentylindol-3-yl-carboxy)naphthylamine (BiPICANA) found in an herbal blend product in the Tokyo metropolitan area and its cannabimimetic effects evaluated by in vitro [35S]GTPγS binding assays". Forensic Toxicology. 33: 84–92. doi:10.1007/s11419-014-0253-6.
  76. "EMB-FUBINACA". New Synthetic Drugs Database.
  77. "FUB-NPB-22". Cayman Chemical. Retrieved 9 May 2015.
  78. "NPB-22". Cayman Chemical. Retrieved 9 May 2015.
  79. Samuel D Banister; Michael Moir; Jordyn Stuart; Richard C Kevin; Katie E Wood; Mitchell Longworth; Shane M Wilkinson; Corinne Beinat; Alxendra S Buchanan; Michelle Glass; Mark Connor; Iain S McGregor; Michael Kassiou (July 2015). "The pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA and 5F-ADBICA". ACS Chemical Neuroscience. 6: 1546–59. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
  80. "5F-PY-PICA". New Synthetic Drugs Database.
  81. "AMB-CHMICA". New Synthetic Drugs Database.
  82. "CBL-018". Cayman Chemical. Retrieved 26 October 2015.
  83. Jenny L. Wiley; Timothy W. Lefever; Ricardo A. Cortes; Julie A. Marusich (September 2014). "Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats". Pharmacology Biochemistry and Behavior. 124: 123–128. doi:10.1016/j.pbb.2014.05.016. PMID 24887450.
  84. Kazlauskas R (2010). "Designer steroids". Handb Exp Pharmacol. 195 (195): 155–85. doi:10.1007/978-3-540-79088-4_7. PMID 20020364.
  85. Abushareeda W, Fragkaki A, Vonaparti A, Angelis Y, Tsivou M, Saad K, Kraiem S, Lyris E, Alsayrafi M, Georgakopoulos C (2014). "Advances in the detection of designer steroids in anti-doping". Bioanalysis. 6 (6): 881–96. doi:10.4155/bio.14.9. PMID 24702116.
  86. Zhang X, Sui Z (2013). "Deciphering the selective androgen receptor modulators paradigm". Expert Opin Drug Discov. 8 (2): 191–218. doi:10.1517/17460441.2013.741582. PMID 23231475.
  87. Zhang X, Li X, Allan GF, Sbriscia T, Linton O, Lundeen SG, Sui Z (January 2007). "Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators". Bioorg. Med. Chem. Lett. 17 (2): 439–43. doi:10.1016/j.bmcl.2006.10.035. PMID 17079140.
  88. Allan GF, Tannenbaum P, Sbriscia T, Linton O, Lai MT, Haynes-Johnson D, Bhattacharjee S, Zhang X, Sui Z, Lundeen SG (2007). "A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats". Endocrine. 32 (1): 41–51. doi:10.1007/s12020-007-9005-2. PMID 17992601.
  89. Kanno Y, Ota R, Someya K, Kusakabe T, Kato K, Inouye Y (2013). "Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression". Biol. Pharm. Bull. 36 (9): 1460–5. doi:10.1248/bpb.b13-00231. PMID 23995658.
  90. Kentaro Takayama; Yuri Noguchi; Shin Aoki; Shota Takayama; Momoko Yoshida; Tomo Asari; Fumika Yakushiji; Shin-ichiro Nishimatsu; Yutaka Ohsawa; Fumiko Itoh; Yoichi Negishi; Yoshihide Sunada; Yoshio Hayashi (February 2015). "Brief Article Prev. Article Next Article Table of Contents Identification of the Minimum Peptide from Mouse Myostatin Prodomain for Human Myostatin Inhibition". Journal of Medicinal Chemistry. 58 (3): 1544–1549. doi:10.1021/jm501170d. PMID 25569186.
  91. "Public Notification: "RigiRx Plus" Contains Undeclared Drug Ingredient". US FDA. 20 April 2012. Retrieved 15 August 2014.
  92. Zhang L, Li P, Hsu T, Aguilar HR, Frantz DE, Schneider JW, Bachoo RM, Hsieh J (Apr 2011). "Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression". Differentiation; Research in Biological Diversity. 81 (4): 233–42. doi:10.1016/j.diff.2011.02.005. PMC 3752777Freely accessible. PMID 21419563.
This article is issued from Wikipedia - version of the 12/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.